GlucoTrack Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for GlucoTrack, Inc. (GCTK) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents5.624.492.316.069.82
Cash & Short-Term Investments5.624.492.316.069.82
Accounts Receivable0.000.000.000.000.07
Inventory0.000.000.000.000.28
Other Current Assets0.150.380.070.040.00
Total Current Assets5.774.872.386.1110.23
Non-Current Assets
Property, Plant & Equipment (Net)0.150.030.040.110.32
Long-Term Investments0.010.000.000.000.00
Other Non-Current Assets0.000.010.020.050.06
Total Non-Current Assets0.160.040.060.160.00
Total Assets5.934.912.446.2710.61
Current Liabilities
Accounts Payable0.990.840.670.630.87
Short-Term Debt0.030.000.000.000.00
Accrued Liabilities0.000.000.330.230.39
Other Current Liabilities0.250.670.340.000.00
Total Current Liabilities1.281.511.010.881.35
Non-Current Liabilities
Long-Term Debt0.240.200.200.210.20
Other Non-Current Liabilities17.420.000.000.000.00
Total Non-Current Liabilities17.660.200.200.230.00
Total Liabilities18.931.711.211.111.62
Stockholders' Equity
Common Stock0.000.000.020.020.02
Retained Earnings-132.45-109.85-101.90-97.47-93.40
Accumulated Other Comprehensive Income-0.010.060.02-0.010.02
Additional Paid-in Capital119.23112.99103.10102.610.00
Shares Outstanding0.010.000.000.000.00
Total Stockholders' Equity-13.003.201.235.168.98
Total Liabilities & Equity5.934.912.446.270.00